Alan Richard Hinman

Alan Richard Hinman's AcademicInfluence.com Rankings

Alan Richard Hinman

Medical

#2766

World Rank

#3199

Historical Rank

Public Health

#425

World Rank

#439

Historical Rank

medical Degrees

Download Badge

Medical

Alan Richard Hinman's Degrees

PhD Health Behavior and Health Education University of North Carolina at Chapel Hill
Masters Health Behavior and Health Education University of North Carolina at Chapel Hill
Bachelors Biology University of North Carolina at Chapel Hill

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Alan Richard Hinman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alan Richard Hinman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Developing an Evidence-Based Guide to Community Preventive Services—Methods (2000) (623)
Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults 1 2 (2000) (585)
Field evaluation of vaccine efficacy. (1985) (521)
Assessing vaccine efficacy in the field. Further observations. (1988) (385)
Promoting informed decisions about cancer screening in communities and healthcare systems. (2004) (318)
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. (1992) (307)
Immunization policies and vaccine coverage among adults. The risk for missed opportunities. (1988) (294)
The immunization system in the United States - the role of school immunization laws. (1999) (266)
Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. (1987) (250)
Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. (2000) (210)
Improving immunization coverage rates: an evidence-based review of the literature. (1999) (205)
Measles outbreak in a pediatric practice: airborne transmission in an office setting. (1985) (196)
Summary and conclusions: measles elimination meeting, 16-17 March 2000. (2004) (187)
Developing the Guide to Community Preventive Services--overview and rationale. The Task Force on Community Preventive Services. (2000) (178)
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. (2000) (175)
Patterns of transmission in measles outbreaks in the United States, 1985-1986. (1989) (161)
Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Task Force on Community Preventive Services. (1999) (136)
Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis. (1993) (131)
Tuberculosis symposium: emerging problems and promise. (1993) (120)
The opportunity and obligation to eliminate measles from the United States. (1979) (117)
Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. (1987) (112)
Eradication of vaccine-preventable diseases. (1999) (110)
Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review. (2005) (108)
Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis. (1993) (107)
Vaccine-preventable diseases; improving vaccination coverage in children, adolescents, and adults : a report on recommendations of the Task Force on Community Preventive Services (1999) (105)
Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis (2017) (103)
Economic analyses of rubella and rubella vaccines: a global review. (2002) (100)
Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs. (1984) (99)
Health impact of measles vaccination in the United States. (1985) (97)
Rubella vaccination in the United States: a ten-year review. (1980) (93)
Immunizations in the United States: success, structure, and stress. (2005) (92)
Measles and Rubella Global Strategic Plan 2012-2020 midterm review. (2018) (87)
Financing immunizations in the United States. (2004) (87)
Measles: Reassessment of the current immunization policy (1989) (84)
Vaccine shortages: history, impact, and prospects for the future. (2006) (84)
Haemophilus influenzae type B conjugate vaccine (1988) (82)
A benefit-cost analysis of a childhood varicella vaccination programme. (1985) (82)
Appropriate age for measles vaccination in the United States. (1986) (80)
Low measles incidence: association with enforcement of school immunization laws. (1981) (80)
THE CASE FOR GLOBAL MEASLES ERADICATION (1982) (79)
A persistent outbreak of measles despite appropriate prevention and control measures. (1987) (78)
Vaccination Mandates: The Public Health Imperative and Individual Rights (2007) (78)
Global progress in infectious disease control. (1998) (77)
What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats. (2019) (76)
State of immunity: The politics of vaccination in twentieth-century America (2007) (72)
Transmission of measles in medical settings. 1980 through 1984. (1986) (71)
Evolution of measles elimination strategies in the United States. (2004) (71)
Vaccine-preventable diseases, immunizations, and MMWR--1961-2011. (2011) (71)
Childhood immunization: laws that work. (2002) (64)
Gonorrhea in preadolescent children: an inquiry into source of infection and mode of transmission. (1977) (62)
Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary. (2018) (59)
Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. (2003) (59)
Fetal risk associated with rubella vaccine: an update. (1985) (58)
What will it take to fully protect all American children with vaccines? (1991) (57)
Overcoming economic barriers to the optimal use of vaccines. (2005) (57)
Prevention of rubella transmission in medical facilities. (1982) (55)
Long-term follow-up after diagnosis resulting from newborn screening: Statement of the US Secretary of Health and Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children (2008) (54)
POLIOMYELITIS IN THE USA: VIRTUAL ELIMINATION OF DISEASE CAUSED BY WILD VIRUS (1984) (53)
Assessment of susceptibility to measles and rubella. (1982) (53)
RATIONAL STRATEGY FOR RUBELLA VACCINATION (1983) (51)
The Russian flu. Its history and implications for this year's influenza season. (1978) (50)
Current features of measles in the United States: feasibility of measles elimination. (1980) (49)
Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks. (1988) (48)
AIDS and absolutism--the demand for perfection in prevention. (1992) (47)
Use of health services. (1982) (47)
The case for global eradication of poliomyelitis. (1987) (46)
Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis. (2016) (46)
Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas. (1998) (45)
Universal influenza vaccination in the United States: are we ready? Report of a meeting. (2006) (45)
Sexually transmitted diseases in the 1990s. (1991) (44)
Major impediments to measles elimination. The modern epidemiology of an ancient disease. (1985) (44)
From the Center for Disease control: current status of measles in the United States, 1973--1977. (1978) (42)
Adherence to Timely Vaccinations in the United States (2020) (41)
Financing vaccines in the 21st century: recommendations from the National Vaccine Advisory Committee. (2005) (38)
Impact of measles in the United States. (1983) (38)
A model to estimate the potential economic benefits of measles eradication for the United States. (1998) (37)
Tuberculous meningitis at Cleveland Metropolitan General Hospital 1959 to 1963. (1967) (37)
Clinical efficacy of rubella vaccine. (1983) (36)
Mortality data analysis using a multiple-cause approach. (1982) (36)
DTP vaccine litigation. (1986) (35)
The opportunity and obligation to eliminate rubella from the United States. (1984) (34)
Immunization registries can be building blocks for national health information systems. (2010) (34)
Morbidity and mortality associated with influenza B in the United States, 1979-1980. A report from the Center for Disease Control. (1980) (32)
Costs of immunization registries: experiences from the All Kids Count II Projects. (2000) (32)
Treatment of bacterial meningitis (1988) (31)
Monitoring system for adverse events following immunization. (1987) (31)
Costs of care. (1982) (31)
Influenza vaccination of health care workers: policies and practices of hospitals in a community setting. (2007) (30)
Immunization in the United States (2008) (30)
Elimination of rubella and congenital rubella from the United States. (1985) (30)
Universal immunization to interrupt rubella. (1985) (30)
American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization of infants and children 2 months of age and older: update. (1991) (30)
Adult immunization: what can we learn from the childhood immunization program? (2007) (30)
History of convulsions and use of pertussis vaccine. (1985) (29)
Assessing prevention effectiveness using data to drive program decisions. (1994) (29)
Parvovirus, Erythema Infectiosum, and Pregnancy (1990) (28)
Development of a US trust measure to assess and monitor parental confidence in the vaccine system. (2019) (28)
Progress in measles elimination. (1982) (28)
Rocky Mountain spotted fever on Long Island. Epidemiologic and clinical aspects. (1971) (28)
Elimination of indigenous measles from the United States. (1983) (27)
Integrating child health information systems. (2005) (26)
Financing Immunization of Adults in the United States (2007) (26)
Imported measles in the United States. (1982) (26)
Immunization information systems: National Vaccine Advisory Committee progress report, 2007. (2007) (26)
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. (1989) (25)
The pertussis vaccine controversy. (1984) (25)
Legislative challenges to school immunization mandates, 2009-2012. (2014) (25)
Nephrotoxicity associated with the use of cephaloridine. (1967) (25)
Immunizations in the United States. (1990) (25)
Linking Children's Health Information Systems: Clinical Care, Public Health, Emergency Medical Systems, and Schools (2009) (25)
From the Center for Disease Control. Current status of rubella in the United States, 1969-1979. (1980) (24)
Pertussis and pertussis vaccine: further analysis of benefits, risks and costs. (1985) (24)
Financing Vaccination of Children and Adolescents: National Vaccine Advisory Committee Recommendations (2009) (23)
Immunization, equity, and human rights. (2004) (23)
Immunisation practice in developed countries (1990) (23)
Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service. (2011) (22)
Streptococcal abscesses following diphtheria‐tetanus toxoid‐pertussis vaccination (1982) (22)
World eradication of measles. (1982) (22)
The Politics of International Health: The Children's Vaccine Initiative and the Struggle to Develop Vaccines for the Third World (1999) (22)
Structuring HIV prevention service delivery systems on the basis of social science theory (1992) (21)
Vaccine-preventable diseases and child day care. (1986) (21)
Strategies to prevent HIV infection in the United States. (1991) (21)
Methods of assessing the impact of congenital rubella infection. (1985) (21)
Principles and core functions of integrated child health information systems. (2004) (21)
Fetal risk associated with rubella vaccine. (1981) (21)
Immunity against measles and rubella in Massachusetts schoolchildren. (1986) (21)
The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships (2019) (20)
Transition Planning For After Polio Eradication (2017) (20)
Newborn dried bloodspot screening: mapping the clinical and public health components and activities (2009) (20)
History and Evolution of the Advisory Committee on Immunization Practices — United States, 1964–2014 (2014) (20)
A cost-effectiveness analysis of measles outbreak control strategies. (1987) (19)
Use of m-Health in polio eradication and other immunization activities in developing countries. (2017) (19)
Epidemiologic and Clinical Aspects (1971) (19)
Worldwide measles prevention. (1994) (19)
Neonatal tetanus: potential for elimination in the world. (1987) (19)
Economic aspects of vaccines and immunizations. (1999) (18)
All Kids Count 1991-2004: developing information systems to improve child health and the delivery of immunizations and preventive services. (2004) (18)
When, where, and how do immunizations fail? (1992) (17)
Partners in Immunization: 2010 Survey Examining Differences among H1N1 Vaccine Providers in Washington State (2013) (17)
Measles: the need for 2 opportunities for prevention. (2006) (17)
From the CDC. Partner notification and confidentiality of the index patient: its role in preventing HIV. (1990) (17)
Assessing risks of rubella infection during pregnancy. A standardized approach. (1981) (17)
1889 to 1989: a century of health and disease. (1990) (15)
Optimized oral cholera vaccine distribution strategies to minimize disease incidence: A mixed integer programming model and analysis of a Bangladesh scenario. (2015) (15)
Methods for conducting systematic reviews of targeted vaccination strategies for the guide to community preventive services. (2005) (15)
American Academy of Pediatrics Committee on Infectious Diseases: The relationship between pertussis vaccine and brain damage: reassessment. (1991) (15)
Economic analyses of vaccine policies (2013) (15)
Perspectives of immunization program managers on 2009-10 H1N1 vaccination in the United States: a national survey. (2012) (15)
Immunization Equity. (2015) (15)
Decision analysis and polio immunization policy. (1988) (14)
Measles and models. (1983) (14)
Building an immunity fence against measles. (2007) (14)
Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP). (2004) (14)
The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles. (1986) (14)
Current epidemiology of pertussis in the United States. (1988) (13)
Disease prevention programs for racial and ethnic minorities. (1993) (13)
Immunization equity. (2015) (13)
Distance learning and distance education: a personal perspective. (1996) (12)
Addressing the vaccine financing conundrum. (2005) (12)
Monitoring Results in Routine Immunization: Development of Routine Immunization Dashboard in Selected African Countries in the Context of the Polio Eradication Endgame Strategic Plan (2017) (12)
International measles importations United States, 1980-1985. (1988) (12)
How Should Physicians and Nurses Deal With People Who Do Not Want Immunizations? (2000) (12)
Measles mortality in the United States 1971-1975. (1980) (12)
Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives (2020) (11)
Measles: the burden of preventable deaths (2012) (11)
Estimated effects of a delay in the recommended vaccination schedule for diphtheria and tetanus toxoids and pertussis vaccine. (1987) (11)
Pneumococcal vaccination practices among private physicians. (1982) (11)
Potential health benefits of child day care attendance. (1986) (11)
American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections. (1985) (11)
A vision for child health information systems: developing child health information systems to meet medical care and public health needs. (2004) (10)
Newborn dried bloodspot screening: Long-term follow-up activities and information system requirements (2010) (10)
Revised Recommendations on Rubella Vaccine (1980) (10)
Measles and rubella: our remaining responsibilities. (1983) (9)
The barefoot doctor: Shanghai County revisited. (1985) (9)
Global Vaccine Action Plan lessons learned III: Monitoring and evaluation/accountability framework (2020) (9)
The eradication of Polio: Have we succeeded? (2017) (9)
Mass Vaccination Against Polio (1984) (9)
Lessons learned from the 2007 to 2009 Haemophilus influenzae type B vaccine shortage: implications for future vaccine shortages and public health preparedness. (2012) (9)
The past, present, and future of immunization in the Americas (2017) (9)
The Condom as Prophylactic (1976) (8)
Performance of the United States Vaccine Injury Compensation Program (VICP): 1988-2019. (2020) (8)
Rubella vaccination of hospital employees. (1981) (8)
Invited Commentary on “The Cutter Incident: Poliomyelitis following Formaldehyde-inactivated Poliovirus Vaccination in the United States during the Spring of 1955. II. Relationship of Poliomyelitis to Cutter Vaccine” (1995) (8)
The US experience with fluoridation. (1996) (8)
Rubella and the Americas. (2003) (8)
Costs of not eradicating measles. (1985) (7)
Progress toward achieving the 1990 immunization objectives. (1983) (7)
Adverse events following immunization with DTP vaccine. (1985) (7)
Quantitative policy analysis and public health policy: a macro and micro view. (1997) (7)
The National Vaccine Advisory Committee at 30: Impact and opportunity (2018) (7)
Public health information systems: from promise to practice. (2002) (7)
Disease prevention in clinical practice. (1976) (7)
Acellular pertussis vaccines. (1987) (7)
Prospects for disease eradication or elimination. (1984) (7)
The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans. (2019) (6)
Hospitalizations for measles, 1970-78. (1982) (6)
The importance of newborn screening. (2001) (6)
Transmission of Measles in Medical Settings (2017) (6)
Prevention of Congenital Rubella Infection: Symposium Summary (1985) (6)
Public Health Policy Toward Atypical Measles Syndrome in the United States (1982) (6)
Measles vaccine in egg-allergic children. (1980) (6)
Landmark perspective: Mass vaccination against polio. (1984) (6)
Nonmedical exemptions to state immunization laws. (2002) (6)
Measles and rubella eradication. (2018) (6)
Update on immunization registries. (2001) (6)
Rubella vaccination strategy. (2007) (6)
American Academy of Pediatrics Committee on Infectious Diseases: The status of acellular pertussis vaccines: current perspective. (1991) (6)
Stakeholder Attitudes Toward Influenza Vaccination Policy in the United States (2010) (6)
Is measles eradicable (1993) (6)
Resurgence of measles in New York. (1972) (5)
Preventive services guidelines for primary care clinicians caring for adults and adolescents infected with the human immunodeficiency virus. (1993) (5)
The current status of immunization principles: recommendations for use and adverse reactions. (1987) (5)
Private Pediatric Clinic Characteristics Associated with Influenza Immunization Efforts in the State of Georgia: A Pilot Evaluation. (2008) (5)
Measles and rubella in adolescents and young adults. (1982) (5)
Invited Commentary: Epidemiology of Transmissible Diseases after Elimination (2000) (5)
Time for the Elimination of Hepatitis C Virus as a Global Health Threat (2020) (5)
Immunization programs. (1980) (5)
Perinatal Herpes Simplex Virus Infections (1980) (5)
An Evaluation of the United States Rubella Immunization Program (1980) (5)
Challenges and changes: Immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response (2014) (4)
The near-term future for child health information systems. (2004) (4)
Imported measles. A potential control problem. (1981) (4)
Perspectives on the state of combination vaccines: summary of the rapporteur for the International Symposium on Combination Vaccines. (2001) (4)
Coalition for Cholera Prevention and Control. (2016) (4)
The sample household health interview survey. (1982) (4)
Integration of Eradication Initiatives and Health Systems (2011) (4)
Perspectives on sustainable vaccine introduction. (2013) (4)
Postpartum rubella immunization. (1986) (4)
Epidemic potential of measles and rubella. (1980) (4)
Decision analysis, public policy, and pertussis: are they compatible? (1987) (4)
Polio Vaccination During Pregnancy-Reply (1983) (4)
DTP vaccine litigation update. (1988) (4)
Rubella: the U. S. experience. (1979) (3)
Collaborating to achieve Global Vaccine Action Plan goals (2017) (3)
Influenza immunization: the U. S. experience. (1979) (3)
Poliomyelitis vaccination for the international traveler. (1982) (3)
Immunization of Indochinese refugees. (1980) (3)
Evaluating interventions for prevention and control of infectious diseases, Part 2. (1998) (3)
The coalition for cholera prevention and control meeting. (2013) (3)
Elimination of cervical cancer: Lessons learned from polio and earlier eradication programs. (2021) (3)
The experience with measles in the United States (1993) (3)
Fighting for the Reputation of Vaccines (2008) (3)
A shot at protection: immunizations against infectious disease. (2007) (3)
The laboratory's role in prevention and control of infectious diseases. (1992) (3)
Is there a need of "catch-up' polio vaccination in preadolescence? (1981) (3)
Evaluation of gonorrhea control efforts. (1975) (3)
Cholera Vaccination in Haiti: Evidence, Ethics, Expedience (2011) (3)
Personal Values as Mediators of Receipt of Non-influenza Childhood Vaccines (2017) (3)
Eradicating measles: a feasible goal? (2007) (3)
Rubella vaccination and pregnancy. (1978) (3)
Influenza and influenza vaccination. (1980) (2)
American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: immunization of children at 15 months of age. (1990) (2)
Neurologic complications of oral poliomyelitis vaccine. (1987) (2)
Vaccination and disease prevention for adults. (1982) (2)
Medical consequences of teenage sexuality. (1975) (2)
What will it take to fully protect all American children with vaccines? An update. (1993) (2)
A shot at success. (1981) (2)
Vaccine Development and Utilization: Summary of the Symposium (1989) (2)
Making the grade: a first attempt at a health and human rights report card. (2006) (2)
Age at pertussis immunization as it relates to current epidemiology and disease control. (1988) (2)
An opportunity to incentivize innovation to increase vaccine safety in the United States by improving vaccine delivery using vaccine patches (2020) (2)
Influenza immunization of health care providers (1988) (2)
Report of the Workgroup on Bacterial Diseases. (1998) (2)
A national survey of immunization programs regarding immunization information systems data sharing and use. (2014) (2)
Measles Vaccination in Infants-Reply (1982) (1)
Integrating Child Health Information Systems (2004) (1)
Dirt and Disease: Polio Before FDR (1994) (1)
Vaccines--Victories and Challenges (2006) (1)
The new U.S. initiative in childhood immunization. (1979) (1)
The U.S. vaccine supply. (2005) (1)
No increased meningoencephalitis after influenza vaccine. (1979) (1)
Special report. Prevention congenital rubella infection: Symposium summary. (1985) (1)
Celebrating the ACIP at 50. (2015) (1)
The National Vaccine Advisory Committee weighs in with eight recommendations for more stable vaccine funding. (2005) (1)
Intravenous γ-Globulin Use in Children With Kawasaki Disease (1988) (1)
Thecaseforglobal eradication ofpoliomyelitis (1987) (1)
Efficacy of acellular pertussis vaccine. (1986) (1)
Evaluating interventions for prevention and control of infectious diseases. (1998) (1)
Tracking Immunization. (2004) (1)
Position Paper (1979) (1)
Management of pregnant patient exposed to varicella. (1979) (1)
Dr. Hinman, et al. Respond (1981) (1)
Emanuel Wolinsky, In Memoriam (2012) (1)
67 – Immunization in the United States (2013) (1)
Measles again. (1980) (0)
Costs of not eradicating measles [editorial] (1985) (0)
DTP Vaccine-Reply (1986) (0)
Ancient and modern plagues. (1991) (0)
Decision Analysis andPolio Immunization Policy (1988) (0)
DTP vaccine litigation. (1986) (0)
42nd annual Louis H. Bauer Lecture. New challenges in prevention. (1996) (0)
II. Transportation systems in the diagnosis of gonorrhea. (1973) (0)
LiveorInactivated Poliomyelitis Vaccine: AnAnalysis ofBenefits andRisks (1988) (0)
VENEREAL DISEASE? (1945) (0)
Injection Technique in Infants-Reply (1983) (0)
Papers on influenza immunization presented at the 14th and 15th Immunization Conferences held 1979 and 2000 (1979) (0)
More on pertussis. (1983) (0)
Vaccination recommendations for persons with diabetes. (1988) (0)
Gonorrhea in upstate New York. (1974) (0)
Rubella vaccination. (1979) (0)
Status of measles elimination (1982) (0)
Analysis, interpretation, use, and dissemination of surveillance information. (1977) (0)
Risks From Polio Vaccination-Reply (1984) (0)
Contributors (2015) (0)
Polio Vaccination-Reply (1987) (0)
Measles Elimination (1986) (0)
Swine flu: problem or panic. (1976) (0)
Fighting for the Reputation of Vaccines. Authors' reply (2008) (0)
Surveillance and the National Center for Prevention Services. (1996) (0)
Russian Influenza in Two University Communities (1981) (0)
Smallpox vaccination dilemma. (1973) (0)
Update: immunizations during pregnancy. (1984) (0)
Measles vaccination. (1979) (0)
Advances in Antiviral Chemotherapy: Amantadine and Influenza (1980) (0)
Commentary: Accelerated measles control/measles elimination in southern Africa. (2002) (0)
Prevention of rubella in hospitals. (1983) (0)
Thanks to reviewers (2023) (0)
Human Immunodeficiency Virus Counseling, Testing, Referral, and Partner Notification Services (2017) (0)
Symposium on public concerns of immunization. Position paper. (1979) (0)
Immunization and disease in New York. (1975) (0)
Vaccine adverse events in the new millennium: is the sky really falling? (2000) (0)
Cost-benefit analysis of rubella screening. (1979) (0)
The United States--The Netherlands Round Table Conference on immunization. Summary report. (1983) (0)
Contributors (2008) (0)
Eliminating Rubella From the United States-Reply (1986) (0)
Support for universal childhood vaccination against influenza among private pediatric clinics and public health departments in Georgia. (2009) (0)
Efficacy of rubella immunization. (1973) (0)
Literature Search We conducted our systematic review and meta-analysis according to the standards for intervention reviews developed by CHERG (2016) (0)
Eradicating measles : a feasible goal ? – PERSPECTIVE (2007) (0)
Walter A. Orenstein, MD: A Tribute from Grateful Pediatric and Public Health Communities (2004) (0)
Immunization Policies and Vaccine Coverage Among Adults (2020) (0)
Vaccine Trials in Schools: We Must Not Ignore Progress. (2019) (0)
New vaccines. (1985) (0)
Dialogue with Dr. Hinman (immunizations for entrance to school). (1974) (0)
Here's How You Can Carry On the Fight against Epidemics in Your Schools. (1983) (0)
Development of a Vaccine Confidence Index for Monitoring and Assessing Parental Confidence in Childhood Vaccination (2017) (0)
A Chance to Live (1992) (0)
Industrial Inorganic Lead Poisoning Epidemic (1980) (0)
Health services in Shanghai County: introduction to Shanghai County. (1982) (0)
Abortions in Tennessee--1975. (1977) (0)
Immunization and malnutrition (1985) (0)
Penicillin in the treatment of gonorrhea. (1972) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alan Richard Hinman?

Alan Richard Hinman is affiliated with the following schools:

Alan Richard Hinman's Academic­Influence.com Rankings